Generics in Brazil
Summary
Generics in Brazil industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and branded generics are included in our market scope. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. Market value is evaluated at ex-factory prices. Market volume refers to the proportion of the total ethical pharmaceutical market in a country or region that is made up of generic drugs. Thus, it is a measure of the market share held by generics, rather than a direct measure of the total market volume. Regional volumes are calculated as averages of countries that comprise the region where volume data exists.
- The Brazilian generics market recorded revenues of $9.2 billion in 2023, representing a compound annual growth rate (CAGR) of 13% between 2018 and 2023.
- Market consumption volume increased with a CAGR of 1.4% between 2018 and 2023, to reach a total of 83.5% of total pharma volume in 2023.
- The growth in consumption volume in the Brazilian generics market is driven by ongoing healthcare reforms, including the expansion of the Farmacia Popular program, which has made essential medicines more affordable for low-income families.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in Brazil
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Brazil
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Brazil generics market with five year forecasts
- What was the size of the Brazil generics market by value in 2023?
- What will be the size of the Brazil generics market in 2028?
- What factors are affecting the strength of competition in the Brazil generics market?
- How has the market performed over the last five years?
- Who are the top competitors in Brazil's generics market?
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Market volume
- 1.4. Market volume forecast
- 1.5. Geography segmentation
- 1.6. Market rivalry
- 1.7. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 3.2. Market volume
- 4 Market Segmentation
- 4.1. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 5.2. Market volume forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What are the strengths/weaknesses of the leading players?
- 7.3. Have there been any recent developments in the market?
- 8 Company Profiles
- 8.1. Sanofi
- 8.2. EMS SA
- 8.3. Ache Laboratorios Farmaceuticos SA
- 8.4. Eurofarma Laboratorios SA
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: Brazil generics market value: $ million, 2018-23
- Table 2: Brazil generics market volume: % of total pharma volume, 2018-23
- Table 3: Brazil generics market geography segmentation: $ million, 2023
- Table 4: Brazil generics market value forecast: $ million, 2023-28
- Table 5: Brazil generics market volume forecast: % of total pharma volume, 2023-28
- Table 6: Sanofi: Key Facts
- Table 7: Sanofi: Annual Financial Ratios
- Table 8: Sanofi: Key Employees
- Table 9: EMS SA: Key Facts
- Table 10: EMS SA: Key Employees
- Table 11: Ache Laboratorios Farmaceuticos SA: Key Facts
- Table 12: Ache Laboratorios Farmaceuticos SA: Key Employees
- Table 13: Eurofarma Laboratorios SA: Key Facts
- Table 14: Eurofarma Laboratorios SA: Key Employees
- Table 15: Brazil Size of Population (million), 2019-23
- Table 16: Brazil Real GDP (Constant 2010 Prices, $ Billion), 2019-23
- Table 17: Brazil GDP (Current Prices, $ Billion), 2019-23
- Table 18: Brazil Inflation, 2019-23
- Table 19: Brazil Consumer Price Index (Absolute), 2019-23
- Table 20: Brazil Exchange Rate, 2018-23
- List of Figures
- Figure 1: Brazil generics market value: $ million, 2018-23
- Figure 2: Brazil generics market volume: % of total pharma volume, 2018-23
- Figure 3: Brazil generics market geography segmentation: % share, by value, 2023
- Figure 4: Brazil generics market value forecast: $ million, 2023-28
- Figure 5: Brazil generics market volume forecast: % of total pharma volume, 2023-28
- Figure 6: Forces driving competition in the generics market in Brazil, 2023
- Figure 7: Drivers of buyer power in the generics market in Brazil, 2023
- Figure 8: Drivers of supplier power in the generics market in Brazil, 2023
- Figure 9: Factors influencing the likelihood of new entrants in the generics market in Brazil, 2023
- Figure 10: Factors influencing the threat of substitutes in the generics market in Brazil, 2023
- Figure 11: Drivers of degree of rivalry in the generics market in Brazil, 2023
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook